What happened
The Canadian Agency for Drugs and Technologies in Health (CADTH), now Canada's Drug Agency, published a rapid review of AI-assisted colonoscopy in December 2024. One reviewer screened the literature published since 2019 and summarized one assessment of the technology, three systematic reviews and one randomized trial. CADTH found that AI-assisted colonoscopy may detect more adenomas, find more per procedure and miss fewer than conventional colonoscopy. It may also lengthen withdrawal times. Differences were not statistically significant in every included study. According to six economic evaluations summarized in the included assessment, AI-assisted colonoscopy is likely to be cost-effective or dominant, meaning less costly and more effective. In the included trial, participants received AI-assisted colonoscopy with either Deep-GI or CAD EYE, and the authors did not compare the two statistically. None of the included studies measured colorectal cancer incidence or deaths, so the effect on those outcomes is unknown. CADTH could not compare systems with each other.
Sources
-
Assessment report, by authors with no tie to the system.
Canadian Agency for Drugs and Technologies in Health. Artificial Intelligence–Assisted Colonoscopy for Detecting Polyps, Adenomas, Precancerous Lesions, and Colorectal Cancer. CADTH Health Technology Review, Report No. RC1559, December 2024. NCBI Bookshelf NBK611312, PMID 39869728 (key messages).
AI-assisted colonoscopy may improve clinical outcomes compared to conventional colonoscopy, including adenoma detection rates, the number of adenomas detected per procedure, and adenoma miss rates, although it may also lead to longer withdrawal times.
Findings from 6 economic evaluations summarized in the HTA suggest that AI-assisted colonoscopy is likely to be cost-effective or dominant — meaning it is less costly and more effective — compared to conventional colonoscopy.
Details
AI system
- Workflow
-
AI-enabled polyp detection ran during colonoscopy alongside the endoscopist. The included studies compared AI-assisted colonoscopy with conventional colonoscopy.
Follow-up
- Conditions for replication
-
Services accept the longer withdrawal times that AI assistance may bring. The extra detections lower colorectal cancer incidence and deaths, which no included study measured.
Entry details
- Sector
-
Healthcare.
- Purpose
-
Fujifilm and other makers built AI-assisted colonoscopy systems to flag polyps for the endoscopist during colonoscopy.
Not yet checked: model, release, provider, role, configuration, inputs and outputs, autonomy, human oversight, beneficiaries, reach, distribution and access, duration, every measurement question, every money question, ownership and control, dependencies, cross-border connections, geopolitical implications, replication attempts, availability, institutional decision, grounds, action and result, success criterion, every evidence question, observed or intended, alternative assessments, related entries, other identifiers, category mappings.
Cite this record
Peter H. Vartanian. (2026). CADTH finds that AI-assisted colonoscopy may detect more adenomas (AIBD-0744). Artificial Intelligence Benefits Database, edition of 31 October 2026. https://petervartanian.xyz/aibd/records/AIBD-0744.html (archived at https://doi.org/10.7910/DVN/AADSII, version 4.0)